DK1232152T3 - Forbedret fremgangsmåde til fremstilling af nitrogensubstituerede aminotetraliner - Google Patents

Forbedret fremgangsmåde til fremstilling af nitrogensubstituerede aminotetraliner

Info

Publication number
DK1232152T3
DK1232152T3 DK00978699T DK00978699T DK1232152T3 DK 1232152 T3 DK1232152 T3 DK 1232152T3 DK 00978699 T DK00978699 T DK 00978699T DK 00978699 T DK00978699 T DK 00978699T DK 1232152 T3 DK1232152 T3 DK 1232152T3
Authority
DK
Denmark
Prior art keywords
nitrogen
preparation
improved process
substituted aminotetralins
aminotetralins
Prior art date
Application number
DK00978699T
Other languages
English (en)
Inventor
Gevork Minaskanian
Keith Rippel
Original Assignee
Aderis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aderis Pharmaceuticals Inc filed Critical Aderis Pharmaceuticals Inc
Application granted granted Critical
Publication of DK1232152T3 publication Critical patent/DK1232152T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
DK00978699T 1999-11-23 2000-11-16 Forbedret fremgangsmåde til fremstilling af nitrogensubstituerede aminotetraliner DK1232152T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16700999P 1999-11-23 1999-11-23
PCT/US2000/031415 WO2001038321A1 (en) 1999-11-23 2000-11-16 Improved process for preparing nitrogen-substituted aminotetralins

Publications (1)

Publication Number Publication Date
DK1232152T3 true DK1232152T3 (da) 2004-04-05

Family

ID=22605581

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00978699T DK1232152T3 (da) 1999-11-23 2000-11-16 Forbedret fremgangsmåde til fremstilling af nitrogensubstituerede aminotetraliner

Country Status (15)

Country Link
US (1) US6372920B1 (da)
EP (1) EP1232152B1 (da)
CN (1) CN1185225C (da)
AR (1) AR026505A1 (da)
AT (1) ATE258927T1 (da)
AU (1) AU1613101A (da)
CA (1) CA2392563C (da)
DE (1) DE60008136T2 (da)
DK (1) DK1232152T3 (da)
ES (1) ES2216992T3 (da)
HK (2) HK1049156B (da)
PL (1) PL202805B1 (da)
PT (1) PT1232152E (da)
TR (1) TR200400401T4 (da)
WO (1) WO2001038321A1 (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19814084B4 (de) 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
DE10041479A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
US20030026830A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
US20030027793A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal treatment of parkinson's disease
US8246979B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine
DE10234673B4 (de) * 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
US8211462B2 (en) * 2002-07-30 2012-07-03 Ucb Pharma Gmbh Hot-melt TTS for administering rotigotine
US8246980B2 (en) * 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system
DE10261696A1 (de) * 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10359528A1 (de) * 2003-12-18 2005-07-28 Schwarz Pharma Ag (S)-2-N-Propylamino-5-hydroxytetralin als D3-agonistisches Therapeutikum
DE10361258A1 (de) * 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
US20050197385A1 (en) * 2004-02-20 2005-09-08 Schwarz Pharma Ag Use of rotigotine for treatment or prevention of dopaminergic neuron loss
DE102004014841B4 (de) 2004-03-24 2006-07-06 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
TWI392670B (zh) * 2006-06-22 2013-04-11 Ucb Pharma Gmbh 經取代的２-胺基萘滿之於製造用於預防、減緩及／或治療各種類型疼痛之藥物上的用途
EP1987815A1 (en) * 2007-05-04 2008-11-05 Schwarz Pharma Ag Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders
WO2008146284A2 (en) * 2007-05-30 2008-12-04 Chemagis Ltd. Crystalline rotigotine base and preparation process therefor
WO2009053697A1 (en) * 2007-10-26 2009-04-30 Pliva Hrvatska D.O.O. Polymorphic forms of ( s ) -rotigotine hydrochloride
WO2009056791A1 (en) * 2007-11-02 2009-05-07 Pliva Hrvatska D.O.O. Processes for preparing pharmaceutical compounds
US8592477B2 (en) * 2007-11-28 2013-11-26 Ucb Pharma Gmbh Polymorphic form of rotigotine and process for production
US20090202647A1 (en) * 2008-02-11 2009-08-13 Mayur Devjibhai Khunt Solid form of racemic rotigotine
IT1392387B1 (it) * 2008-09-26 2012-03-02 Solmag S P A Ora Fidia Farmaceutici S P A Processo per la preparazione di rotigotina
MX2011005979A (es) 2008-12-09 2011-06-27 Interquim Sa Procedimiento de obtencion de (6s)-(-)-5,6,7,8-tetrahidro-6-[propi l-(2-tienil)etil]amino-1-naftol(rotigotina).
WO2010073124A2 (en) 2008-12-26 2010-07-01 Actavis Group Ptc Ehf Processes for preparing highly pure rotigotine or a pharmaceutically acceptable salt thereof
EP2281559A1 (en) 2009-06-26 2011-02-09 UCB Pharma GmbH Pharmaceutical composition comprising rotigotine salts (acid or Na), especially for iontophoresis
CN102010400B (zh) 2009-09-07 2015-02-04 药源药物化学（上海）有限公司 S-5-取代-n-2'-(噻吩-2-基-)乙基-1,2,3,4-四氢萘-2-胺或其手性酸盐和用于制备罗替戈汀
EP2490673A2 (en) 2009-10-19 2012-08-29 Actavis Group Ptc Ehf Amorphous rotigotine co-precipitates
DE102009052972A1 (de) 2009-11-12 2011-09-15 Lts Lohmann Therapie-Systeme Ag Verfahren zur Verhinderung der Kristallisation von Arzneistoffen in einem Polymerfilm
DK2515887T3 (da) 2009-12-22 2018-09-17 Ucb Biopharma Sprl Polyvinylpyrrolidon til stabilisering af en faststofdispersion af den ikke-krystallinske form af rotigotin
EP2531486B1 (en) 2010-02-05 2017-06-21 UCB Biopharma SPRL Novel process for the preparation of nitrogen substituted aminotetralins derivatives
AU2011268871C1 (en) * 2010-06-25 2015-06-04 Ucb Pharma Gmbh Processes for the resolution of nitrogen substituted (S) - 5 -alkoxy- 2 -aminotetralin derivatives
ES2626024T3 (es) 2011-06-27 2017-07-21 Shan Dong Luye Pharmaceutical Co., Ltd. Procedimiento para preparar industrialmente amino-5,6,7,8-tetrahidronaftol sustituido con nitrógeno
CN103768043B (zh) * 2012-10-22 2015-12-09 苏州药明康德新药开发股份有限公司 采用羟丙基-β-环糊精配制四氢化萘类化合物均一稳定溶液的方法
US10611749B2 (en) 2018-02-15 2020-04-07 Solara Active Pharma Sciences Limited Process for preparation of Rotigotine and intermediates thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0026848B1 (de) 1979-09-14 1983-05-04 Sandoz Ag Tetralinderivate, ihre Herstellung und Heilmittel, welche diese Verbindungen enthalten
US4564628A (en) 1983-01-03 1986-01-14 Nelson Research & Development Co. Substituted 2-aminotetralins
US4968837A (en) 1989-07-28 1990-11-06 Ethyl Corporation Resolution of racemic mixtures
US5382596A (en) * 1993-08-05 1995-01-17 Whitby Research, Inc. Substituted 2-aminotetralins

Also Published As

Publication number Publication date
CA2392563A1 (en) 2001-05-31
CA2392563C (en) 2011-02-15
PL202805B1 (pl) 2009-07-31
TR200400401T4 (tr) 2004-03-22
DE60008136D1 (de) 2004-03-11
CN1391569A (zh) 2003-01-15
HK1052514A1 (zh) 2003-09-19
AR026505A1 (es) 2003-02-12
PL355607A1 (en) 2004-05-04
US6372920B1 (en) 2002-04-16
EP1232152B1 (en) 2004-02-04
DE60008136T2 (de) 2004-09-09
EP1232152A1 (en) 2002-08-21
CN1185225C (zh) 2005-01-19
ATE258927T1 (de) 2004-02-15
AU1613101A (en) 2001-06-04
WO2001038321A1 (en) 2001-05-31
ES2216992T3 (es) 2004-11-01
PT1232152E (pt) 2004-06-30
HK1049156B (zh) 2004-12-10
HK1049156A1 (en) 2003-05-02

Similar Documents

Publication Publication Date Title
DK1232152T3 (da) Forbedret fremgangsmåde til fremstilling af nitrogensubstituerede aminotetraliner
DK1173431T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1105382T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1159274T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1123284T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK1309545T3 (da) Fremgangsmåde til fremstilling af alkylarylsulfonater
DK1309581T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1165576T3 (da) Fremgangsmåde til fremstilling af amin-platin-komplekser
DK1380121T3 (da) Fremgangsmåde til fremstilling af oxazolidinoner
EE200300294A (et) Sulfoonamiid-asendatud imidasotriasinoonide valmistamismeetod
DK1958938T3 (da) Fremgangsmåde til fremstilling af 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepin-5-carboxamid
DK1028960T3 (da) Fremgangsmåde til fremstilling af thiazolidinedion
DK1296970T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1190114T3 (da) Fremgangsmåde til fremstilling af nikkelhydroxider
DK0973769T3 (da) Fremgangsmåde til fremstilling af eprosartan
DK0985733T3 (da) Fremgangsmåde til fremstilling af cyclodextrin
DK1228056T3 (da) Fremgangsmåde til fremstilling af citalopram
DK0970073T3 (da) Fremgangsmåde til fremstilling af eprosartan
DK1203000T3 (da) Fremgangsmåde til fremstilling af phosphonomethylglycin
DK1075473T3 (da) Fremgangsmåde til fremstilling af 1,3-disubstituerede-4-oxocykliske urinstoffer
DK1240173T3 (da) Fremgangsmåde til fremstilling af N-phosphonomethylglycin
DK1373232T3 (da) Fremgangsmåde til fremstilling af N-substituerede 2,6-dialkylmorpholiner
NO20030515L (no) Fremgangsmåte for fremstilling av dinapsolin